List view / Grid view

News

Anavex releases preclinical anti-seizure data for ANAVEX 2-73

18 May 2015 | By Victoria White

Anavex revealed full preclinical anti-seizure data for its lead drug candidate, ANAVEX 2-73, at the Antiepileptic Drug Trials XIII Conference...

Ablynx and Genzyme to collaborate on multiple sclerosis research project

18 May 2015 | By Victoria White

Ablynx is set to collaborate with Genzyme to investigate Nanobodies against a target that plays an important role in multiple sclerosis (MS)...

Contraceptive and cholesterol-lowering drug combination (BaP) used to treat cancer

15 May 2015 | By Victoria White

The BaP combination of a cholesterol-lowering drug, bezafibrate and a contraceptive steroid could be an effective treatment for a range of cancers.

Lilly and Sanford-Burnham to collaborate to discover immunological therapies

15 May 2015 | By Victoria White

Eli Lilly and Company and Sanford-Burnham Medical Research Institute are to collaborate to discover and develop immunological therapies...

Anisina confirmed as effective anti-cancer agent in preclinical studies

14 May 2015 | By Victoria White

Novogen has confirmed that drug candidate, Anisina, is an effective monotherapy against human melanoma in an animal model...

Acucela announces publication of preclinical data for emixustat

14 May 2015 | By Victoria White

Acucela has announced the publication of preclinical data related to the Company’s investigational drug candidate emixustat hydrochloride...

Antibiotic Research UK welcomes the O’Neill Commission’s recommendation to create $2b global fund to tackle antibiotic resistance

14 May 2015 | By Victoria White

Antibiotic Research UK has welcomed this latest report to come from Jim O’Neill's Review on Antimicrobial Resistance and has endorses its recommendations...

Immunomic Therapeutics awarded $1.2m to develop peanut allergy treatment

13 May 2015 | By Victoria White

Immunomic Therapeutics has been awarded a US $1.2 million grant for the development of its ARA-LAMP-vax technology against peanut allergies...

Sanofi exercises option on second therapeutic programme with Selecta Biosciences to develop a treatment for coeliac disease

13 May 2015 | By Victoria White

Under the terms of an existing agreement with Selecta, Sanofi has exercised its option to an exclusive license to develop a treatment of coeliac disease...

Page 421 of 449
<
1
...
416
417
418
419
420
421
422
423
424
425
...
449
>

Cookie	Type	Duration	Description
cookielawinfo-checkbox-advertising-targeting	persistent	1 year	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics	persistent	1 year	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	persistent	1 year	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	persistent	1 year	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID	session	1 year	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy	persistent	1 year	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged	session	1 year	This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.

Cookie	Type	Duration	Description
advanced_ads_browser_width	persistent	1 month	This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions	persistent	2 years	This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info	persistent	1 month	This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer	persistent	1 year	This cookie is set by Advanced Ads and sets the referrer URL.
bscookie	persistent	2 years	This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE	persistent	2 years	This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr	persistent	3 months	This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory	persistent	1 month	This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE	persistent	5 months	This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.

Cookie	Type	Duration	Description
bcookie	persistent	2 years	This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS	persistent	30 minutes	This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang	session	1 year	This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc	persistent	1 day	This cookie is set by LinkedIn and used for routing.
lissc	persistent	11 months	This cookie is set by LinkedIn share Buttons and ad tags.
vuid	persistent	2 years	We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId	persistent	2 years	This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule	persistent	20 minutes	This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session	persistent	20 minutes	This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues	persistent	20 minutes	This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga	persistent	2 years	This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat	persistent	1 minute	This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid	persistent	1 day	This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

Cookie	Type	Duration	Description
cf_ob_info	persistent	1 minute	This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob	persistent	1 minute	This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only	session	1 year	This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush	persistent	1 month	This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db	persistent	Until cleared	This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC	session	1 year	This cookie is set by Youtube and is used to track the views of embedded videos.

Recommended

News

Anavex releases preclinical anti-seizure data for ANAVEX 2-73

Ablynx and Genzyme to collaborate on multiple sclerosis research project

Contraceptive and cholesterol-lowering drug combination (BaP) used to treat cancer

Lilly and Sanford-Burnham to collaborate to discover immunological therapies

Anisina confirmed as effective anti-cancer agent in preclinical studies

Acucela announces publication of preclinical data for emixustat

Antibiotic Research UK welcomes the O’Neill Commission’s recommendation to create $2b global fund to tackle antibiotic resistance

Immunomic Therapeutics awarded $1.2m to develop peanut allergy treatment

Sanofi exercises option on second therapeutic programme with Selecta Biosciences to develop a treatment for coeliac disease

Genethon and Selecta Biosciences to research repeat dosing for gene therapies

Soligenix enters agreement with Emergent BioSolutions to develop ricin vaccine RiVax

Invectys initiates Phase I clinical trial evaluating INVAC-1 therapeutic vaccine for cancer patients

New “map” of TTLL7 protein helps researchers understand cellular transport

Significant progress made towards individualised cancer immunotherapy

Haplogen and Cyclenium Pharma announce research and development collaboration